Deep vein thrombosis: heparin and warfarin is more effective than warfarin
alone.
|
|
|
Clinical bottom line (level 1b)
-
In patients with proximal deep vein thrombosis, giveing heparin
while awaiting satisfactory oral anticoagulation reduces symptomatic DVT
recurrence
(NNT =
8
at 6
months)
.
-
The effect on major bleeding is unclear.
|
|
Brandjes et al:
New England Journal of Medicine
1992;
327 (21):
1485-1489
|
Expires
May 2003
|
The study
Double-blinded concealed randomised
trial
with
intention-to-treat
Setting: acute hospital, Holland
120 patients
(aged
mean 57 years,
54%
female)
proximal deep vein thrombosis, diagnosed by
venogram
Excluded if
previously diagnosed DVT
clinically suspected pulmonary embolism, bilateral venous
thrombus or plegmasia when referred
received anticoagulation
pregnant
<18 or >85 years old
life expectancy of <6 months
coagulation-inhibitor deficiency
refused consent
Control Group: (n = 60, 60 analysed):
heparin
iv 5000 units bolus dose, then 1250 units per hour for seven
days, plus
acenocoumarol
6 mg on first day, then 4 mg on second
day, then titred so that INR 2.0-3.0- continued for 12 weeks
Experimental Group: (n = 60, 60 analysed):
acenocoumarol
alone
100% followed for
6
months
The evidence
| Outcome |
Time to outcome |
CER | EER | RRR (95% CI) | ARR (95% CI) | NNH (95% CI) |
| symptomatic recurrence
|
6
months |
4 (6.67%) |
12 (20.0%) |
-200% (-780% to
-3%) |
-13.3% (-25.3% to
-1.41%) |
8
(4 to
71)
|
| major bleed
|
6
months |
2 (3.33%) |
3 (5.00%) |
-50% (-770% to
74%) |
-1.67% (-8.81% to
5.48%) |
60
(NNT =
18
to infinity;
NNH = 11 to infinity)
|
Comments
- 78% of patients had a recognisable cause.
Citation
-
Brandjes
DPM,
Heijboer
H,
Buller
HR, et al:
Acenocoumarol and heparin compared with acenocoumarol
alone in the initial treatment of proximal-vein thrombosis.
New England Journal of Medicine
1992;
327 (21):
1485-1489
Contributor: Bob Phillips, Chris Ball and Clare Wotton,
May 2000
Reviewer: James Douketis
Clinical Question.
| Patient |
proximal DVT |
| Intervention or Exposure |
heparin plus acenocoumarol /
warfarin |
| Comparison |
acenocoumarol / warfarin |
| Outcome |
recurrence |
|
|